Axalta Coating Systems
AXTA · NYSE
About AXTA
- Employees
- 12,300
- Headquarters
- PHILADELPHIA, Pennsylvania
- Listed
- Nov 12, 2014
- Sector
- Materials
- Industry
- Chemicals
- Website
- axalta.com
AXTA key statistics
- Market cap
- 7.50B
- Price-earnings ratio
- 21.64
- Dividend yield
- —
- Average volume
- 1.88M
- Volume
- 1.80M
- Open price
- $34.53
- High today
- $34.75
- Low today
- $33.89
- 52 Week high
- $38.61
- 52 Week low
- $24.94
Axalta Coating Systems (AXTA) at a glance
As of Oct 23, 2026, Axalta Coating Systems (AXTA) shares are priced at $34.14, giving the company a market cap of 7.50B and a price-to-earnings ratio of 21.64.
Today the stock has traded between $33.89 and $34.75. The current price is 0.8% above the day's low and 1.8% below its high.
Volume so far is 1.80M shares, in line with the average of 1.88M shares a day.
Over the past year Axalta Coating Systems has ranged from $24.94 to $38.61, and now sits 67% of the way up that range.
Axalta Coating Systems met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.72 per share against an estimate of $0.6657.
The average analyst price target is $39.79, 16.5% above the current price, from 12 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy41.7%
- Hold58.3%
- Sell0.0%
- Low
- $33.33
- Now
- $34.14
- High
- $49.35
AXTA earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 8.1% on average.
- Q3 FY24: reported $0.59 per share against an estimate of $0.5222
- Q4 FY24: reported $0.60 per share against an estimate of $0.5215
- Q1 FY25: reported $0.59 per share against an estimate of $0.5546
- Q2 FY25: reported $0.64 per share against an estimate of $0.6229
- Q3 FY25: reported $0.67 per share against an estimate of $0.6541
- Q4 FY25: reported $0.59 per share against an estimate of $0.6169
- Q1 FY26: reported $0.56 per share against an estimate of $0.5129
- Q2 FY26: reported $0.72 per share against an estimate of $0.6657
AXTA news
- Chris Katje
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote--CCRN, EQH, AXTA, and CZNL
- Press releasePRNewswire
Are RMAX, AXTA, CRBG, EQH Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
Axalta Coating Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axalta Coating Systems Ltd. - AXTA
- Press releasePRNewswire
Are DAN, PAYO, AXTA Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, NUVL, AXTA, and PFLC
- Press releasePRNewswire
Are AXTA, KPLT, FTHM, ALOT Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
Are AXTA, GBTG, D, EVTV Obtaining Fair Deals for their Shareholders?
Similar companies
Companies in the same industry as Axalta Coating Systems
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.